ConductScience.org, home

Trial · NCT04246047

Adverse events446

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherThrombocytopeniaBlood and lymphatic system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)167242501
otherThrombocytopeniaBlood and lymphatic system disordersDaratumumab + Bor + Dex122246269
otherAnaemiaBlood and lymphatic system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)4524266
otherAnaemiaBlood and lymphatic system disordersDaratumumab + Bor + Dex64246110
otherNeutropeniaBlood and lymphatic system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)3424283
otherNeutropeniaBlood and lymphatic system disordersDaratumumab + Bor + Dex2724651
otherLymphopeniaBlood and lymphatic system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)2124244
otherLymphopeniaBlood and lymphatic system disordersDaratumumab + Bor + Dex2324638
otherLeukopeniaBlood and lymphatic system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)1424242
otherLeukopeniaBlood and lymphatic system disordersDaratumumab + Bor + Dex1024617
otherPeripheral sensory neuropathyNervous system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)6124281
otherPeripheral sensory neuropathyNervous system disordersDaratumumab + Bor + Dex5124668
otherNeuropathy peripheralNervous system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)5024259
otherNeuropathy peripheralNervous system disordersDaratumumab + Bor + Dex5524670
otherDizzinessNervous system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)2124224
otherDizzinessNervous system disordersDaratumumab + Bor + Dex1924620
otherHeadacheNervous system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)2124225
otherHeadacheNervous system disordersDaratumumab + Bor + Dex1824620
otherPolyneuropathyNervous system disordersBelantamab Mafodotin + Bortezomib (Bor) + Dexamethasone (Dex)1524217
otherPolyneuropathyNervous system disordersDaratumumab + Bor + Dex1324614

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04246047/events